Dr. Olander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
622 Smithview Dr
Maryville, TN 37803Phone+1 865-681-1234Fax+1 865-982-9746
Education & Training
Louisiana State University School of Medicine (New Orleans)Residency, Ophthalmology, 1977 - 1980
Tulane UniversityInternship, Transitional Year, 1976 - 1976- Tulane University School of MedicineClass of 1976
Certifications & Licensure
TN State Medical License 1997 - 2025- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 10 citationsA Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6).Kenneth Olander, Michelle Sato, Marc A Abrams, Gary Jerkins, Fenghe Lu
Journal of Glaucoma. 2021-06-01 - 40 citationsFixed combination of latanoprost and timolol vs individual components for primary open-angle glaucoma or ocular hypertension: a randomized, double-masked study.Eve J. Higginbotham, Kenneth W. Olander, Elizabeth E. Kim, John W. Grunden, Kenneth Kwok
Archives of Ophthalmology. 2010-02-01 - 1 citationsRelationship between visual field severity and response to fixed combination dorzolamide/timolol or timolol alone.Kenneth W. Olander, Vincent A. Galet, Gang Jia, Steven S. Smugar, William C. Stewart
Journal of Ocular Pharmacology and Therapeutics. 2009-08-03
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
